Minneslate Logo

SF3786 (Legislative Session 94 (2025-2026))

Epilepsy-related prescription drugs and medical supplies cost sharing limitation provision

Related bill: HF3652

AI Generated Summary

Purpose

  • The bill aims to limit cost-sharing (copayments and coinsurance) for epilepsy-related prescription drugs and medical supplies, by amending Minnesota Statutes 2024 section 62Q.481 subdivision 2.

Main Provisions

  • Section amendment: Changes Minnesota Statutes 2024 section 62Q.481 subdivision 2.
  • Definitions introduced:
    • Chronic disease: includes diabetes, asthma, epilepsy, and allergies that require the use of epinephrine autoinjectors.
    • Costsharing: defined as copayments and coinsurance.
    • Related medical supplies: includes syringes, insulin pens, insulin pumps, test strips, glucometers, continuous glucose monitors, epinephrine autoinjectors, asthma inhalers, and other medical supply items necessary to effectively treat a chronic disease or to administer a prescription drug for a chronic disease.
  • Purpose tied to cost-sharing limits: The definitions and wording are set up to establish or clarify limits on out-of-pocket costs for epilepsy-related prescription drugs and the medical supplies used to manage epilepsy and other chronic diseases.

Significant Changes to Existing Law

  • Adds explicit definitions to clarify what counts as a chronic disease and what counts as related medical supplies for the purposes of cost-sharing rules.
  • Applies cost-sharing limitations to epilepsy-related prescription drugs and related medical supplies, with broader reference to chronic diseases through the defined terms (e.g., chronic disease, related medical supplies).

Potential Impact

  • May reduce out-of-pocket costs for individuals purchasing epilepsy-related medications and the listed related supplies.
  • Provides clearer criteria for what counts as covered under cost-sharing limits, potentially affecting insurers and patients who use these drugs and supplies.

Relevant Terms

  • cost-sharing
  • copayments
  • coinsurance
  • epilepsy
  • epilepsy-related prescription drugs
  • chronic disease
  • diabetes
  • asthma
  • allergies
  • epinephrine autoinjectors
  • related medical supplies
  • syringes
  • insulin pens
  • insulin pumps
  • test strips
  • glucometers
  • continuous glucose monitors
  • asthma inhalers
  • Minnesota Statutes 62Q.481
  • Subdivision 2

Bill text versions

Actions

DateChamberWhereTypeNameCommittee Name
February 23, 2026SenateActionIntroduction and first reading
February 23, 2026SenateActionReferred toCommerce and Consumer Protection

Citations

 
[
  {
    "analysis": {
      "added": [
        "Definitions for chronic disease, cost-sharing, and related medical supplies added to Subd. 2."
      ],
      "removed": [],
      "summary": "This bill relates to health insurance cost-sharing and amends Minnesota Statutes 2024 section 62Q.481, subdivision 2, by adding definitions for chronic disease and related medical supplies to limit cost-sharing for epilepsy-related prescription drugs and medical supplies.",
      "modified": [
        "Subd. 2 amended to read with revised definitions."
      ]
    },
    "citation": "62Q.481",
    "subdivision": "Subd. 2"
  }
]

Progress through the legislative process

17%
In Committee

Sponsors

Loading…